FOLD - Amicus announces U.K. approval and launch of Pompe disease therapy
2023-08-15 08:34:15 ET
More on Amicus Therapeutics
- Amicus Therapeutics Inc. ( FOLD ) Q2 2023 Earnings Call Transcript
- Amicus Therapeutics: Finally The FDA Inspection Is Done, Time To Be Positive
- Amicus Therapeutics reports mixed Q2 earnings; updates FY23 outlook
- Amicus' Opfolda combo for Pompe disease on track for EU approval after EMA nod
- Seeking Alpha’s Quant Rating on Amicus Therapeutics
- Earnings data for Amicus Therapeutics
For further details see:
Amicus announces U.K. approval and launch of Pompe disease therapy